Telephone Contact Between Hospital and General Practitioner About Medication Review for Older Patients

Study Overview
=================
Brief Summary
-----------------
In this trial, the feasibility of cooperation between clinical pharmacists and physicians by conducting a telephone follow-up conversation between the hospital geriatrician, the general practitioner and the clinical pharmacist is evaluated. During hospital stay the clinical pharmacist and the geriatrician will review older patients' medication and discuss the future treatment with the general practitioner after discharge by telephone or medico-technology. The first part of the feasibility study will be a qualitative baseline measure of characteristics of the participants and work flow. The second part will be a pilot randomized controlled study where participants will be allocated to either usual care or medication review and follow up contact

Official Title
-----------------
Can Telephone Contact After Discharge Between Geriatrician, Clinical Pharmacist and General Practitioner About Medication Review in Hospital Improve the Medication in Older Patients? A Feasibility Study.

Conditions
-----------------
Older Patients, Medication Review, Cross-sectional Communication

Intervention / Treatment
-----------------
* Behavioral: Medication review


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: * 5 drugs or more Exclusion Criteria: Terminal illness Not able to speak and understand Danish

Ages Eligible for Study
-----------------
Minimum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Health Services Research
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Intervention<br>Medication history by pharmaconomist. Medication review by pharmacist, patient interview, and conference with physician in hospital, telephone contact to general practitioner after discharge, medication report sent to primary care. | Behavioral: Medication review<br>* Conducted by the pharmacist and discussed with hospital physician<br>|
| No Intervention: Control<br>Medication history by pharmaconomist. Usual care by physicians. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Changes in number of medications | Increase or decrease in number of medications from admission to discharge | At admission and at discharge | 
| Parts of the intervention completed | In the intervention Group only, it is measured, how many of the elements of the intervention the patient actually have received | Day 1 after discharge | 
| Changes in the Electronic Medication Profile (FMK) | How many changes have been Applied to the Electronic Medication Profile | 14 days after discharge | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of readmissions | Data from registers | within 30 days after discharge | 
| Number of emergency visits | Data from registers | within 30 days after discharge | 
| Number of visits at general practitioner | Data from registers | within 30 days after discharge | 
| Patient satisfaction with the discharge | Measured by telephone interview | 14 days after discharge | 
| Changes in patient-experienced quality of life | Measured by telephone interview using the 5-item questionnaire EQ-5D, where each question can be answered on a 5-point Likert Scale ranging from very high degree of problems to very low degree of problems | At admission and 14 days after discharge | 
| Health care professionals satisfaction | Measured by a questionnaire | 3 months after implementation |